Physicians’ awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a “Pituitary Society” survey

[1]  E. Kanal,et al.  The Impact of Gadolinium Deposition on Radiology Practice: An International Survey of Radiologists. , 2018, Current problems in diagnostic radiology.

[2]  D. Levine,et al.  Gadolinium Retention After Contrast-Enhanced MRI , 2018, JAMA.

[3]  R. Lenkinski,et al.  Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. , 2018, Radiology.

[4]  L. Oleaga,et al.  High Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted MR Images in Melanoma Patients Receiving MacrocyclicGadolinium-Based Contrast , 2018 .

[5]  C. Corot,et al.  Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals , 2018, Investigative radiology.

[6]  M. Kirchin,et al.  Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats , 2017, Journal of magnetic resonance imaging : JMRI.

[7]  I. Dekkers,et al.  Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency , 2018, European Radiology.

[8]  Michael A. Paolini,et al.  Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities. , 2017, Radiology.

[9]  Cyprian Olchowy,et al.  The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review , 2017, PloS one.

[10]  R. Semelka,et al.  Gadolinium deposition disease: Initial description of a disease that has been around for a while. , 2016, Magnetic resonance imaging.

[11]  N. Oyesiku,et al.  Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas. , 2016, Neurosurgery.

[12]  D. Reich,et al.  National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain. , 2016, Journal of the American College of Radiology : JACR.

[13]  D. Stojanov,et al.  Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents—current status , 2016, Neuroradiology.

[14]  D. Reich,et al.  NIH Perspective on Reports of Gadolinium Deposition in the Brain , 2016 .

[15]  A. Tabarin,et al.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. , 2015, The Journal of clinical endocrinology and metabolism.

[16]  W. Woodmansee,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE MANAGEMENT FOLLOWING PITUITARY SURGERY. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[17]  Shigeru Furui,et al.  Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. , 2015, Radiology.

[18]  Pascal J. Kieslich,et al.  Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. , 2015, Radiology.

[19]  E. Laws,et al.  Acromegaly: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[20]  Vincenzo Di Lazzaro,et al.  Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation , 2014, Investigative radiology.

[21]  Daisuke Takenaka,et al.  High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. , 2014, Radiology.

[22]  G. Baillie,et al.  Lanthanum-induced neurotoxicity: solving the riddle of its involvement in cognitive impairment? , 2013, Archives of Toxicology.

[23]  M. Han,et al.  Immediate hypersensitivity reaction to gadolinium-based MR contrast media. , 2012, Radiology.

[24]  Martin R Prince,et al.  Incidence of nephrogenic systemic fibrosis at two large medical centers. , 2008, Radiology.

[25]  J. Provenzale,et al.  Nephrogenic systemic fibrosis: possible association with a predisposing infection. , 2008, AJR. American journal of roentgenology.

[26]  Frank J Rybicki,et al.  Biochemical safety profiles of gadolinium‐based extracellular contrast agents and nephrogenic systemic fibrosis , 2007, Journal of magnetic resonance imaging : JMRI.